{{if listFind(vars.channel_names, "MSIF News")}}

{{endif}}

{{if listFind(vars.channel_names, "MSIF News")}}

{{endif}}

{{if listFind(vars.channel_names, "People With MS News")}}

{{endif}}

{{if listFind(vars.channel_names, "People With MS News")}}

{{endif}}

{{if listFind(vars.channel_names, "Research News")}}

{{endif}}

{{if listFind(vars.channel_names, "Research News")}}

{{endif}}

{{if listFind(vars.channel_names, "MS Society News")}}

{{endif}}

{{if listFind(vars.channel_names, "MS Society News")}}

{{endif}}

Can you help us find new data for the Atlas of MS?

Over the last 17 months, MSIF and the World Health Organization (WHO) have been gathering epidemiology and service delivery data from countries around the world for the WHO/MSIF Atlas of MS publication. This data has also been presented on the Atlas of MS website at www.atlasofms.org. We now need your help to gather more.

read more

MS in focus - pain edition out in July

In July 2007, MSIF will be publishing an edition of MS in focus magazine about pain and MS. Sign up now to receive your free copy!

read more

Projects added to the Quality of Life Principles Practice Database

MSIF is pleased to confirm that the US and Germany MS societies have already added projects to the new database, which aims to share good practice globally.

read more

back to top

Profile of the Month : June 2008

Amal AbdulRahman

Age: 32
Country: Saudi Arabia
Occupation: Freelance teacher and translator
Year of diagnosis: 2001

"You are, through your soul not your body, a human being."

English Italiano Espanol Deutsch Francais Russian Arabic (May 2007 only)

read more

back to top

Environmental risk factors for multiple sclerosis. Part II: Noninfectious factors

The authors review all the noninfectious environmental risk factors thought to contribute to the occurrence of MS. Among these sun exposure and vitamin D intake are discussed as likely protective factors.

authors: Ascherio A, Munger KL.

source: Ann Neurol. 2007 May 10

read more

The involvement of mitochondria in the pathogenesis of multiple sclerosis.

The authors review the important role of mitochondria, little cell components necessary to transform oxygen into energy, in the pathogenesis of MS.

authors: Kalman B, Laitinen K, Komoly S.

source: J Neuroimmunol. 2007 May 8

read more

ICOS gene haplotypes correlate with IL10 secretion and multiple sclerosis evolution

This study addressed the complex role of genes in MS, finding that a specific genetic pattern could reduce the number of clinical episodes in people with relapsing MS.

authors: Castelli L, Comi C, Chiocchetti A, Nicola S, Mesturini R, Giordano M, D'Alfonso S, Cerutti E, Galimberti D, Fenoglio C, Tesser F, Yagi J, Rojo JM, Perla F, Leone M, Scarpini E, Monaco F, Dianzani U.

source: J Neuroimmunol. 2007 May 2

read more

fMRI changes in relapsing-remitting multiple sclerosis patients complaining of fatigue after IFNbeta-1a injection

The authors, using a recently introduced MRI technique, looked at the fatigue occurring in people with MS after injections of interferon-beta. They found it to be caused by dysfunction of specific brain areas.

authors: Rocca MA, Agosta F, Colombo B, Mezzapesa DM, Falini A, Comi G, Filippi M.

source: Hum Brain Mapp. 2007 May;28(5):373-82.

read more

back to top

Genetics consortium finds gene that may protect against MS

source: US National MS Society

The International MS Genetics Consortium (IMSGC) has newly identified a gene that may help protect people from developing multiple sclerosis.

read more

EU legislation to facilitate stem cell derived treatments one step closer

source: EMSP

The European Parliament has backed a compromise package on a proposed EU regulation on advanced therapies, including those derived from stem cells. The proposed EU Regulation will facilitate development of those treatments as it will replace 27 national regulatory frameworks with the one EU framework. Additionally, after a hard battle, the decision on ethics of treatment derived, for example, from human embryonic stem cells, is finally left to member states.

read more

Progress on experimental therapies for MS, and much more, reported at the American Academy of Neurology meeting

source: US National MS Society

More than 10,000 researchers and practicing neurologists from around the world gathered at the 59th Annual Meeting of the American Academy of Neurology in Boston, USA from April 28-May 4. Well over 200 presentations were about multiple sclerosis.

read more

back to top

Tell a friend

The email you subscribed with us is {{print email}}

Within this newsletter the following options are available: MSIF News; People with MS News; Research News and MS Society News. To amend your options please login to the 'My world of MS' online community where you can also read diary entries from people affected by MS, leave your own diary entries and send messages to other users. You can also change your email address, contact details and subscribe to our free publications.

If you have an RSS News Reader you can get the latest news syndicated to you by copying the following link to your Reader: Syndicate.

If you do not want to receive future issues of this newsletter or if you have received this in error, please accept our apologies and simply unsubscribe here

Multiple Sclerosis International Federation
3rd Floor Skyline House, 200 Union Street, SE1 0LX
Tel: +44 (0) 20 7620 1911
Fax: +44 (0) 20 7620 1922
Registered Charity: 1105321
Email: info@msif.org

 Click here to learn more about the work of the Making Connections sponsor.